I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled “Workforce Readiness Technology Minimizes Risk in Clinical Trials” and it explores how ArcheMedX is enabling Sponsors, CROs, and other trial stakeholders to improve clinical trial readiness.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
Related Post
Breaking the Cycle of Poorly Executed Site Initiation Visits
Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled…
ArcheMedX Team
Connect with ArcheMedX at SCOPE 2023
The ArcheMedX team is energized to attend the annual SCOPE Summit of Clinical Operations Executives…
ArcheMedX Team
ArcheMedX To Present New Findings & Clinical Trial Innovations At The CNS Summit
Analyses of 42,656 clinician learners across 69 CNS-related educational activities reveals clinicians may be unprepared…
